Pioneering Early Cancer Diagnostics with Next-Generation Rapid Testing Solutions

Our Mission

At OncoFirm™ Diagnostics, It’s Personal.

Cancer isn’t just a medical challenge—it’s deeply personal. Every member of our team has been touched by it: a parent, a sibling, a best friend, a child. We’ve sat in waiting rooms, felt the heartbreak of uncertainty, and held on to hope for more time.

That shared experience unites us and fuels our purpose. We are not only scientists, engineers, and professionals—we are daughters, sons, friends, and survivors. Having stood on both sides of a diagnosis, we made a promise: to create solutions that truly matter.

Our mission is simple yet profound: to empower healthcare professionals, patients, and pet owners with the ability to detect cancer early enough to fight back. Early detection isn’t just science—it’s hope, it’s time, it’s a second chance.

At OncoFirm, our diagnostics are more than tests. They are lifelines. Built with empathy and precision, they carry the weight of what’s at stake: a graduation, an anniversary, another tomorrow.

We are accelerating the fight against cancer in two critical arenas:

• Human Healthcare: Delivering fast, accurate, and accessible rapid diagnostics that bring lab-grade results to the point of care, reducing delays and improving survival outcomes.
• Companion Animal Care: Pioneering a new standard in veterinary medicine with affordable, point-of-care cancer screening—empowering veterinarians and protecting the pets that families cherish.

This is not just our work—it is our stand, our promise, our movement. By transforming pain into purpose and science into solutions, we are building a world where early detection is the rule, not the exception.

OncoFirm™ Diagnostics exists to save lives—human and animal—by making early cancer detection fast, accessible, and universal.

We will empower doctors, hospitals, clinics, veterinarians and diagnostic laboratories with highly sensitive and reliable rapid cancer tests, enabling early detection, improved patient outcomes, and personalized treatment pathways.

Our Technology

Our lateral flow tests offer much higher sensitivity, provide quantitative capability, reduce false positives and negatives, and are ideal for detecting low-concentration analytes. Enables cost-effective, point-of-care testing with rapid results in minutes, eliminating the need for complex laboratory infrastructure. Using highly specific antigen biomarkers associated with multiple types of cancers, enhancing test sensitivity and early-stage cancer detection.

Non-Invasive & Scalable Solutions: Designed for oncology screening programs, hospital diagnostics, and research institutions focusing on cancer and infectious diseases.

Who We Serve?
Hospitals & Clinics – Streamlining cancer diagnostics for early intervention and treatment planning.
Doctors & Oncologists – Providing rapid and reliable screening tools to enhance patient care.
Diagnostic Laboratories – Delivering innovative assays for precise cancer biomarker detection.
Cancer Screening Programs – Supporting large-scale early detection initiatives to improve survival rates.
Oncology & Infectious Disease Research – Advancing biomarker research for new therapeutic discoveries.

Why Choose Us?
✅ Rapid Results: LFA-based tests provide results in under 15 minutes.
✅ Highly Sensitive & Specific: based assays enhance early-stage cancer detection.
✅ Easy-to-Use & Non-Invasive: Designed for point-of-care settings with minimal training required.
✅ Cost-Effective & Scalable: Ideal for large-scale screening programs and clinical applications.

At OncoFirm Diagnostics, we are committed to driving the future of cancer diagnostics with groundbreaking biomarker-based rapid testing. Our innovations empower healthcare providers with faster, more accurate, and accessible tools for early cancer detection, ensuring better patient outcomes and improved survival rates worldwide.

For partnerships and inquiries, contact us at: investor@oncofirmdiagnostics.com